Researchers at the University of Montreal Hospital Research Center say they have developed a multimodal optical spectroscopy probe that could provide patients with common widespread forms of cancer longer life expectancies and lower risk of recurrence.
The team, which began work on the probe in 2015, have refined the invention and designed a new device with improved accuracy, sensitivity and specificity that they claim is capable of not only detecting brain cancer cells, but colon, lung and skin cancer cells as well.
Read the whole story at our sister site, Medical Design & Outsourcing